Skip to content
Menu

Amneal Pharmaceuticals, Inc. AMRX

Full chart Compare
Set alert

Price alert · AMRX

All alert types
21.12 USD -0.27 (-1.26%)

Regular-session close

21.78 +0.66 +3.15%

After hours · Nov 20, 6:11 PM ET

21.07 Day range 21.70
11.52 52-week range 21.88
YTD
+67.62%
1 year
+83.33%

AMRX revenue history

Revenue is income from the company’s ordinary business activities.

3,018,760,000 USD

FY 2025 · Period ended

Coverage: complete. Values in USD; not inflation adjusted.

Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.

Scroll the table to see all values →

Revenue · annual · USD
Fiscal periodPeriod endRevenueYoY changeYoY %
FY 20252025-12-313,018,760,000224,803,0008.05%
FY 20242024-12-312,793,957,000400,350,00016.73%
FY 20232023-12-312,393,607,000181,303,0008.20%
FY 20222022-12-312,212,304,000118,635,0005.67%
FY 20212021-12-312,093,669,000101,146,0005.08%
FY 20202020-12-311,992,523,000366,150,00022.51%
FY 20192019-12-311,626,373,000-36,618,000-2.20%
FY 20182018-12-311,662,991,000629,337,00060.88%
FY 20172017-12-311,033,654,00015,429,0001.52%
FY 20162016-12-311,018,225,000151,945,00017.54%
FY 20152015-12-31866,280,00080,657,00010.27%
FY 20142014-12-31785,623,000Not availableNot available

Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.

Company-reported financial statements. Retrieved 2026-11-11T07:00:37.000Z. Retrieval time is not a report date.

Open full statements

Use Add to watchlist above to save this stock.